60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) EBIT per Share : $0.00 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals EBIT per Share?

60 Degrees Pharmaceuticals's EBIT per Share for the three months ended in Mar. 2024 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.

During the past 3 years, the average EBIT per Share Growth Rate was -170.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for 60 Degrees Pharmaceuticals's EBIT per Share or its related term are showing as below:

SXTPW' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -170.2 Med: -170.2 Max: -170.2
Current: -170.2

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of 60 Degrees Pharmaceuticals was -170.20% per year. The lowest was -170.20% per year. And the median was -170.20% per year.

SXTPW's 3-Year EBIT Growth Rate is ranked worse than
98.77% of 1305 companies
in the Biotechnology industry
Industry Median: 3.6 vs SXTPW: -170.20

60 Degrees Pharmaceuticals's EBIT for the three months ended in Mar. 2024 was $0.43 Mil.

60 Degrees Pharmaceuticals EBIT per Share Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals EBIT per Share Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial							-	-	-	-	-

60 Degrees Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

60 Degrees Pharmaceuticals's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.527	/	0
=	N/A

60 Degrees Pharmaceuticals's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.429	/	0
=	N/A

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

60 Degrees Pharmaceuticals (NAS:SXTPW) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

60 Degrees Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.